Drug Design & Discovery
From target identification to clinical approval — the science behind new medicines
Drug design and discovery is the multidisciplinary process of developing new medicines — from identifying a biological target to clinical approval. Understanding this pipeline is essential for pharmacists and healthcare professionals working in medicines development, regulation, and optimisation.
What is Drug Design & Discovery?
Drug design and discovery refers to the scientific and regulatory process by which new therapeutic agents are identified, optimised, tested, and approved for clinical use. The process begins with target identification — understanding a biological molecule (such as a receptor, enzyme, or ion channel) that plays a key role in a disease. Once a target is validated, researchers screen large libraries of chemical compounds to identify candidates that interact with it favourably. Modern approaches include rational drug design, structure-based design, and high-throughput screening, often aided by computational modelling.
Stages of Drug Development
Once a promising lead compound is identified, it progresses through a structured pipeline: hit-to-lead optimisation improves potency and selectivity; preclinical studies assess safety, pharmacokinetics, and toxicology in cell and animal models; followed by Phase I (healthy volunteer safety), Phase II (efficacy and dose-finding in patients), Phase III (large-scale randomised controlled trials), and Phase IV (post-marketing surveillance). Regulatory bodies such as the EMA and FDA evaluate the evidence before granting a marketing authorisation. The average drug takes 10 to 15 years and over £1 billion to reach the market.
Pharmacist Role in Drug Development
Pharmacists contribute across the drug development pipeline — from formulation science and pharmacokinetic analysis to clinical trial pharmacy and regulatory affairs. In clinical trials, pharmacists ensure investigational medicinal product accountability, storage, dispensing, and patient counselling. In industry, pharmacists work in regulatory submissions, pharmacovigilance, and medical affairs. Understanding drug design principles also supports evidence-based prescribing, enabling pharmacists to critically evaluate new medicines, assess therapeutic equivalence, and contribute to formulary decisions.